ASH
Polygenic Risk Score Shows Potential in Personalizing Chemotherapy for Pediatric AML Patients
Premium
At ASH's annual meeting, researchers reported that patients with low scores on a 10-SNP test fared better when they got clofarabine plus the standard 7+3 course of chemo.
NGS Bests Flow Cytometry for MRD-Based Prediction of ALL Relapse, Survival, ASH Study Suggests
Premium
In a retrospective analysis, ALL patients tested with NGS were less likely to achieve MRD-negative status than when tested with flow cytometry.